Print

Novartis Pharmaceuticals Canada Inc. (NVS) Pulls Prexige From Canada on Safety Issues  
10/4/2007 10:04:38 AM

Novartis Pharmaceuticals Canada Inc. has complied with a request from Health Canada to cease the sales and marketing in Canada of Prexige, a COX-2 selective inhibitor for the treatment of osteoarthritis, effective immediately.
//-->